PXS
Pyxis Tankers Inc.
PXS has the edge over RKLB overall, supported by lower modeled downside and stronger modeled upside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
PXS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
PXS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
PXS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.6x | $1.32 | -77% |
| Fair | 2.4x | $1.92 | -66% |
| Forward | 3.7x | $5.65 | — |
| Current | 7x | $5.65 | — |
| Expensive | 18x | $14.30 | +153% |
Historical ranges are pointers, not guarantees.
PXS's PE is in its expensive range at 7.0x. If earnings grow as analysts expect, today's price would be 3.7x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
PXS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for PXS, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PXS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.52 | +88% |
| Q3 2024 | $2.76 | +18% |
| Q2 2024 | $2.73 | +7.1% |
| Q1 2024 | $2.54 | -6.3% |
| Q4 2023 | $3.57 | +237% |
| Q3 2023 | $2.34 | +$2.37 |
| Q2 2023 | $2.55 | +$3.42 |
| Q1 2023 | $2.71 | +$4.11 |
| Q4 2022 | $1.06 | +$2.40 |
PXS has the stronger earnings trend. Trailing diluted EPS is down 70% for PXS versus RKLB down 192%.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
PXS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $12.1M | +33% |
| Q1 2026 | $10M | +3.9% |
| Q4 2025 | $10.5M | -12% |
| Q3 2025 | $9.7M | -30% |
| Q2 2025 | $9.2M | -34% |
| Q1 2025 | $9.6M | -19% |
| Q4 2024 | $12M | -9.2% |
| Q3 2024 | $13.8M | +24% |
PXS's revenue is recovering but still below its 2022 peak: $12M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 36% | +46 points |
| Q1 2026 | 34% | +17 points |
| Q4 2025 | 29% | +19 points |
| Q3 2025 | 22% | -12 points |
| Q2 2025 | -9.5% | -54 points |
| Q1 2025 | 16% | -22 points |
| Q4 2024 | 11% | -35 points |
| Q3 2024 | 34% | -2.5 points |
PXS has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over PXS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
PXS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.8M | +88% |
| Q1 2026 | $3.4M | -17% |
| Q4 2025 | $2.3M | -62% |
| Q3 2025 | $3.3M | +78% |
| Q2 2025 | $3.1M | +$17.6M |
| Q1 2025 | $4.1M | +$23.9M |
| Q4 2024 | $6.1M | +$7.3M |
| Q3 2024 | $1.9M | +$23.4M |
PXS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
PXS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -98.3K shares |
| 1 year | -1.7% | -172K shares |
| 3 years | -19% | -2.4M shares |
| 5 years | +40% | +2.9M shares |
| Available history | +94% | +5M shares |
PXS has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $74,849 |
| Q1 2026 | $586,000 |
| Q4 2025 | $204,363 |
| Q3 2025 | $2,004 |
| Q2 2025 | $10,417 |
| Q1 2025 | $270,000 |
| Q4 2024 | $1.8M |
| Q3 2024 | $436,000 |
PXS spent $867,216 buying back its own shares over the past year, down 66% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PXS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.5x | Moderate |
| Q3 2024 | 1.3x | Healthy |
PXS's net debt is about 1.1 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PXS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.9 | Neutral |
| Stochastic | 40.3 | Neutral |
PXS's weekly RSI is 49 (neutral) and its Stochastic is 40 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
PXS PE vs Industrials Sector
| Metric | PXS | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 24x | 71% below |
| PE % | 72 | 58 | 14 pts above |
PXS is trading at 7.0x earnings, a 71% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
PXS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.91 | 18% below |
| 20 week MA | $5.93 | 4.7% below |
| 50 week MA | $4.68 | 21% above |
| 100 week MA | $3.89 | 45% above |
| 200 week MA | $4.20 | 35% above |
PXS has slipped below its 8- and 20-week averages, though it's still 35% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
PXS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.48 | $3.25 | -27% |
| 2021 | $3.25 | $2.15 | -34% |
| 2022 | $2.15 | $5.20 | +142% |
| 2023 | $5.20 | $4.17 | -20% |
| 2024 | $4.17 | $3.67 | -12% |
| 2025 | $3.67 | $2.95 | -20% |
| 2026 YTD | $2.95 | $5.65 | +92% |
PXS has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.